What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
Jonathan D. Smith focuses on Internal medicine, Endocrinology, Cholesterol, Apolipoprotein E and Apolipoprotein B.
His work deals with themes such as Lesion, Antioxidant and In vivo, which intersect with Internal medicine.
His Endocrinology study incorporates themes from Inflammation and Transgene.
Jonathan D. Smith works mostly in the field of Cholesterol, limiting it down to concerns involving Trimethylamine N-oxide and, occasionally, Gut flora.
His work carried out in the field of Apolipoprotein E brings together such families of science as Pathogenesis, Aorta, Ratón, Monocyte and Alzheimer's disease.
The study incorporates disciplines such as Endocytosis, Lipoprotein particle and Losartan, Angiotensin II receptor antagonist in addition to Apolipoprotein B.
His most cited work include:
- Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease (2806 citations)
- Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis (2176 citations)
- Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells (1990 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Endocrinology, Cholesterol, Apolipoprotein E and Biochemistry.
Internal medicine is often connected to Cardiology in his work.
His Endocrinology research integrates issues from Inflammation, Immunology, Macrophage and In vivo.
His Cholesterol research is multidisciplinary, relying on both Efflux and Myeloperoxidase.
His research integrates issues of Lesion, Genetically modified mouse, Transgene, Molecular biology and Alzheimer's disease in his study of Apolipoprotein E.
His Reverse cholesterol transport research includes elements of ABCA1 and High-density lipoprotein.
He most often published in these fields:
- Internal medicine (38.06%)
- Endocrinology (33.20%)
- Cholesterol (31.17%)
What were the highlights of his more recent work (between 2018-2021)?
- Atrial fibrillation (12.96%)
- Internal medicine (38.06%)
- Gene (14.98%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Atrial fibrillation, Internal medicine, Gene, Bioinformatics and In vitro.
Jonathan D. Smith works mostly in the field of Atrial fibrillation, limiting it down to topics relating to Mitochondrion and, in certain cases, Heart failure, Oxidative phosphorylation, Sinus rhythm and Sirtuin.
His Internal medicine research incorporates elements of Endocrinology and Cardiology.
His studies examine the connections between Endocrinology and genetics, as well as such issues in Proteomics, with regards to Inflammation.
Jonathan D. Smith focuses mostly in the field of In vitro, narrowing it down to topics relating to Genetic enhancement and, in certain cases, Cholesterol.
He works in the field of Cholesterol, focusing on Apolipoprotein B in particular.
Between 2018 and 2021, his most popular works were:
- SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy. (41 citations)
- SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy. (41 citations)
- SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy. (41 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
His main research concerns 2019-20 coronavirus outbreak, Spike Protein, Angiotensin II Receptor Blockers, Severe acute respiratory syndrome coronavirus 2 and Bioinformatics.
His 2019-20 coronavirus outbreak research includes elements of In patient and In vitro.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
